(Q52918160)

9 May 2018

meta-analysis

0 references

title

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. (English)

1 reference

9 May 2018

0 references

1 reference

1

1 reference

9 May 2018

Gioacchino Leandro

2

1 reference

9 May 2018

author name string

G Niro

3

1 reference

9 May 2018

A Mangia

4

1 reference

9 May 2018

V Festa

5

1 reference

9 May 2018

G Gambassi

6

1 reference

9 May 2018

M R Villani

7

1 reference

9 May 2018

D Facciorusso

8

1 reference

9 May 2018

P Conoscitore

9

1 reference

9 May 2018

F Spirito

10

1 reference

9 May 2018

G De Maio

11

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

9 May 2018

Gastrointestinal Endoscopy

published in

1 reference

9 May 2018

volume

51

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

1-7

1 reference

9 May 2018

Complications of endoscopic biliary sphincterotomy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

ERCP- and endoscopic sphincterotomy-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Endoscopic sphincterotomy complications and their management: an attempt at consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Meta-analytic tools for medical decision making: a practical guide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

Effect of somatostatin analog octreotide on human sphincter of Oddi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2800%2970377-4

10.1016/S0016-5107(00)70377-4

7 January 2021

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

10625786

1 reference

9 May 2018